Despite the lack of reimbursement under HRSA’s COVID-19 Uninsured Program, CDC has released a new FAQ for participants in the Federal Retail Pharmacy Program stating their expectation that participating providers will continue to administer COVID-19 vaccines to the uninsured at no cost.

Pharmacists are important providers on the patient’s health care team and play a critical role in the use of medications for the treatment of acute, subacute, and chronic pain. Accordingly, APhA submitted comments on CDC’s proposed 2022 update to the 2016 opioid prescribing guideline.

The Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises the U.S. Congress on issues affecting the Medicare program began to delve into its treasure trove of information from pharmacy benefit managers (PBMs) during a public meeting last week with initial findings to be published in its June report to Congress.

APhA is urging our members to respond to the Federal Trade Commission’s (FTC’s) request for information how the large, vertically merged PBMs’ unfair, deceptive, and anticompetitive business practices have impacted your pharmacy and patients.

HHS Secretary Xavier Becerra again renewed the COVID-19 public health emergency declaration (PHE declaration), effective April 16. The current PHE will now expire on July 15, 2022.